BBTS Conference 2016


SaBTO and blood safety

Day: Thursday  |   Time: 14:00 - 15:30   |  Room: 1

Available Presentations

Sexual behaviours and the blood donor: do selection criteria matter?

Su Brailsford

Download Presentation

Pathogen Inactivation as an Alternative to Platelet Screening
Jennifer Allen

Download Presentation

Pigs or blood - which to blame?
Mike Ankcorn

Download Presentation

Abstract Oral Presentation:

An unexpected constituent of fresh frozen plasma
Tim Wreford-Bush

The quality of standard and neonatal apheresis platelet concentrates with pathogen inactivation treatment using the INTERCEPT blood system
Susan Proffitt

Download Presentation

Session Coordinators: Steve Thomas and Jo Tossell

Speakers: 

Su Brailsford
NHS Blood and Transplant and Public Health England Epidemiology Unit

Professor Richard Tedder
NHS Blood and Transplant and Public Health England Blood Borne Virus Unit

Jennifer Allen
National Bacteriology Laboratory, NHS Blood and Transplant

Intended Audience: TBC

Learning Objectives: 

  1. To understand the impact of donor behaviour on blood safety
  2. Awareness of risk reduction measures for hepatitis E.  
  3. Knowledge of the efficacy of pathogen inactivation systems versus bacterial contamination of platelets.  

Brief Description: 

The session will provide updates on current and recent work emanating from the UK governments' advisory committee on the Safety of Blood, Tissues and Organs (SaBTO).  

Donor selection criteria are currently under review, and outcomes from a behavioural survey will be presented.  The prevalence of hepatitis E virus is rising and selective testing of blood donations was introduced in early 2016 - a review of the epidemiology and the development of clinical guidelines will be presented. 

Pathogen inactivation of platelet concentrates is a potential mitigation of the risk of bacterial contamination.  Data will be presented from laboratory studies on the efficacy of two licensed systems versus species of bacteria that have been found in platelet concentrates.  

Sessions Include:

Sexual behaviours and the blood donor: do selection criteria matter?

Su Brailsford

Pathogen Inactivation as an Alternative to Platelet Screening
Jennifer Allen

Pigs or blood - which to blame?
Prof Richard Tedder

Abstract Oral Presentation:

An unexpected constituent of fresh frozen plasma
Tim Wreford-Bush

The quality of standard and neonatal apheresis platelet concentrates with pathogen inactivation treatment using the INTERCEPT blood system
Susan Proffitt


Session Tags: